ICT&health January 19, 2026
Delivering personalised, timely follow-up care after prostate cancer treatment is becoming increasingly complex. To support clinicians and improve continuity of care, the Department of Radiation Oncology at Mayo Clinic has developed the PSA Control Tower: an intelligent monitoring solution that uses AI to help identify early signs of disease recurrence.
Traditionally, prostate cancer follow-up relies on fixed schedules and manual review of test results. While effective, this approach is time-consuming and can delay action when subtle but clinically relevant changes occur. As patient volumes rise and care pathways become more complex, health systems face growing pressure to deliver reliable follow-up without increasing the burden on care teams.
PSA-values
At the heart of prostate cancer monitoring are prostate-specific antigen (PSA) values...
Today's Sponsors
Today's Sponsor